Aposcience AG
Wien, AT· latest recorded location
APOSCIENCE AG is named on 4 US grants and 11 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 4
- Published applications
- 11
- Inventors
- 3
- Granted in 2026 so far
- 0
- Most recent grant
- 17 May 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 3 |
| 2012 | 0 | 1 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 2 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year.
Technology areas
Share of 15 documents
- A61KMedicines and medical preparations9
- A61PTherapeutic uses of medicines9
- C12NMicroorganisms or enzymes6
- G01NInvestigating or analysing materials by determining their chemical or physical properties6
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2
- A61QSpecific use of cosmetics or similar toiletry preparations1
- C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition1
Recent patents
- Potency assay of secretomes17 May 2022US 11,333,662 B2
- Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture1 Feb 2022US 11,235,003 B2
- Pharmaceutical preparation19 Nov 2019US 10,478,456 B2
- COPD diagnosis9 Apr 2013US 8,415,112 B2
- Composition for treating or preventing vasculitis and diseases associated with vasculitis27 Feb 2025US 2025/0064850 A1
- Treatment of skin scars20 Jun 2024US 2024/0197781 A1
- Composition for treating or preventing an allergy or allergic reaction5 Jan 2023US 2023/0000910 A1
- Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture and method of use21 Apr 2022US 2022/0118020 A1
- Potency assay of secretomes10 Dec 2020US 2020/0386740 A1
Most cited
By later US patents